Press Release Sep 04 2021

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2021, titled "Dr. Reddy s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).".

View Attachment